AI assistant
Sending…
Actinium Pharmaceuticals, Inc. — Director's Dealing 2016
Aug 30, 2016
34570_dirs_2016-08-30_a54d3d01-878f-45d7-a9e1-d11cc96f0481.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-08-26
Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-26 | Common Stock | S | 12998 | $1.7 | Disposed | 4939490 | Direct |
| 2016-08-26 | Common Stock | S | 12002 | $1.71 | Disposed | 4927488 | Direct |
| 2016-08-29 | Common Stock | S | 12500 | $1.71 | Disposed | 4914988 | Direct |
| 2016-08-29 | Common Stock | S | 12500 | $1.72 | Disposed | 4902488 | Direct |
More from Actinium Pharmaceuticals, Inc.
Delisting Announcement
2026
May 29
Annual Report
2026
Mar 30
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 26
Board/Management Information
2026
Feb 13
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26
Interim / Quarterly Report
2025
Nov 14
Annual Report
2025
Nov 5
Proxy Solicitation & Information Statement
2025
Nov 5
Director's Dealing
2025
Aug 20
Interim / Quarterly Report
2025
Aug 8